Cordis ADROIT 6F Guiding Catheter Product Usage: For intravascular introduction of interventi...

FDA Device Recall #Z-0003-2014 — Class II — August 12, 2013

Recall Summary

Recall Number Z-0003-2014
Classification Class II — Moderate risk
Date Initiated August 12, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Cordis Corporation
Location Miami Lakes, FL
Product Type Devices
Quantity 1238 units

Product Description

Cordis ADROIT 6F Guiding Catheter Product Usage: For intravascular introduction of interventional and/or diagnostic devices into the coronary or peripheral vascular system.

Reason for Recall

Due to a labeling error related to the conversion of the inner diameter of the catheter from inches to millimeters. The English dimension is correct and is the primary dimension.

Distribution Pattern

Worldwide Distribution - USA Nationwide in the states of AZ, CA, FL, ID, LA, MA, MD, MI, MN, MO, NC, NH, NY, OH, OK, PA, SC, TX, VA, WI, and WV and the countries of: Austria, Belgium, Czech Republic, France, Germany, Greece,Hungary, Israel, Italy, Latvia, Netherlands, Poland, Portugal, Russian Federation, Slovenia, Spain, Sweden, Switzerland, United Arab, and United Kingdom

Lot / Code Information

Catalog Lots ---------------------------------- 67200000 15918614 67200200 15892736 67200400 15892737, 15897416 67200500 15901314 67203400 15922021 67203600 15897418 67204000 15925687 67205200 15892738, 15892739 67205400 15885645, 15887472, 15897420 67205600 15901319 67206000 15897422 67207200 15892740 67208000 15892741 67208200 15887473, 15887474, 15897424 67208300 15901321 67212600 15916942 67213000 15916943 67227000 15901323

Other Recalls from Cordis Corporation

Recall # Classification Product Date
Z-0221-2022 Class II SMART FLEX 10x100 BIL, 120cm The S.M.A.R.T.¿ F... Oct 1, 2021
Z-0216-2022 Class II SMART FLEX 9x60 BIL, 80cm The S.M.A.R.T.¿ Flex... Oct 1, 2021
Z-0220-2022 Class II SMART FLEX 10x100 BIL, 80cm The S.M.A.R.T.¿ Fl... Oct 1, 2021
Z-0218-2022 Class II SMART FLEX 6x150 BIL, 120cm The S.M.A.R.T.¿ Fl... Oct 1, 2021
Z-0219-2022 Class II SMART FLEX 8x60 BIL, 80cm The S.M.A.R.T.¿ Flex... Oct 1, 2021

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.